We are monitoring the impact of COVID-19 on Asia Pacific In Situ Hybridization Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 6795
Share on
Share on

Asia-Pacific In Situ Hybridization Market Research Report – Segmented By Technique, Application, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 6795
Pages: 145

APAC In Situ Hybridization Market Size (2021 to 2026)

The size of the Asia Pacific in Situ Hybridization Market was worth USD 147.27 million in 2021 and estimated to be growing at a CAGR of 5.95%, to reach USD 196.62 million by 2026.

Cancer is one of the significant driving forces for the APAC in situ hybridization market. Over the past decades, extensive studies related to human diseases such as cancer have been conducted, recognizing that recurrent genomic abnormalities are possible drivers of a variety of cancers. According to GLOBOCAN, in 2019, 44.2 million people had cancer and 9.7 million deaths from cancer. In addition, there were around 18.5 million new cases in 2019. Thus, cancer incidence could reach 29.7 million, with a death rate of 16.9 million by 2040. Other genetic disorders such as hemophilia, thalassemia and sickle cell anemia, etc., also increase steadily over time. According to research conducted, the incidence of hemophilia has tripled to 1,126,000, compared to previous estimates of 401,000. The countries most affected are India, China, Australia, and New Zealand. This increase is likely to pull the market during the projected period.

Several technological developments in cytogenetic assays enable researchers to develop, discover and implement novel diagnostic procedures for gene expression in situ at the RNA level. This will provide unique insight into the interaction between cancer cells and the tumor microenvironment as cancer progresses. In developed countries, high-quality molecular diagnostic tests are already available. The market is expected to be driven by the unmet demand in developing countries, including India and China, which offer significantly in situ hybridization opportunities. Other factors such as increasing geriatric populations, growing rate of infectious diseases and cancer, better ability to detect abnormalities related to congenital malformations or mental disorders, expansion of health care infrastructure, to study familial history, and increased investments by respective government agencies and key players in the region are responsible for expanding the APAC in situ hybridization market during the forecast period.

However, in situ hybridization is a technique-sensitive procedure; the inability of probes to detect target sequences after a few repetitions may not provide desired results, which may restrain the market. In addition, other factors such as the high cost of the probes, strict government regulations, and approval, the low detection capability of fluorescent in situ hybridization for significant patient abnormalities, the lack of a commercial market for diagnostic procedures, and the long-time taken for detection procedures are expected to hamper the APAC in situ hybridization market. These factors have resulted in the limited availability of diagnostic tests and their adaptability, especially in emerging economies.

This research report on APAC In situ hybridization market has been segmented and sub-segmented into the following categories.

By Technique:

  • FISH
  • CISH

By Application:

  • Cancer Diagnosis
  • Neuroscience
  • Cytology
  • Infectious Disease

By End User:

  • Molecular Diagnostic Laboratories
  • Academic and Research Institutions

By Type:

  • DNA
  • RNA

By Product:

  • Instruments
  • Probes & Kits

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the APAC region is expected to play a dominating role in the global in situ hybridization market during the forecast period due to the increasing incidence and diagnosis of cancer in Australia and China, attributed to the increase in clinical cancer research by biotechnology companies and pharmaceuticals, the increase in medical tourism, government initiatives and the increasing use of complementary diagnostics.

In Japan, the in-situ hybridization market is estimated to register a healthy CAGR during the forecast period. At the same time, China is projected to lead the regional market.

In terms of growth, Australia is the second-largest market for APAC in situ hybridization due to favorable government policies regarding the development of healthcare infrastructure, increased biomedical research activities dedicated to hybridization techniques, increased prevalence and diagnosis of cancer, the growing trend for a sedentary lifestyle and increased per capita spending. Other APAC regions will also support market growth attributed to economic growth and technological advancements in medicine and healthcare in South Korea, New Zealand, and the Philippines.

KEY MARKET PLAYERS:

A few of the notable companies operating in the APAC in situ hybridization market profiled in this report are Abbott Laboratories, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Leica Biosystems Nussloch GmbH (Germany), Agilent Technologies (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), Exiqon A/S (Denmark), BioGenex Laboratories, Inc. (U.S.), Advanced Cell Diagnostics, Inc. (U.S.), and Bio SB Inc. (U.S.).

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Technique                   

                                5.1.1 Introduction           

                                5.1.2 FISH           

                                5.1.3 CISH           

                                5.1.4  Y-o-Y Growth Analysis, By Technique         

                                5.1.5  Market Attractiveness Analysis, By Technique       

                                5.1.6  Market Share Analysis, By Technique         

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Cancer Diagnosis  

                                5.2.3 Neuroscience        

                                5.2.4 Cytology   

                                5.2.5 Infectious Disease               

                                5.2.6 Y-o-Y Growth Analysis, By Application         

                                5.2.7 Market Attractiveness Analysis, By Application       

                                5.2.8 Market Share Analysis, By Application        

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Molecular Diagnostic Laboratories

                                5.3.3 Academic And Research Institutions            

                                5.3.4 Y-o-Y Growth Analysis, By End User             

                                5.3.5  Market Attractiveness Analysis, By End User          

                                5.3.6  Market Share Analysis, By End User            

                5.4 Type                              

                                5.4.1 Introduction           

                                5.4.2 DNA           

                                5.4.3 RNA           

                                5.4.4 Y-o-Y Growth Analysis, By Type     

                                5.4.5  Market Attractiveness Analysis, By Type 

                                5.4.6 Market Share Analysis, By Type     

                5.5 Product                        

                                5.5.1 Introduction           

                                5.5.2 Instruments           

                                5.5.3 Probes & Kits         

                                5.5.4 Y-o-Y Growth Analysis, By Type     

                                5.5.5  Market Attractiveness Analysis, By Type 

                                5.5.6 Market Share Analysis, By Type     

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Technique

                                                6.1.3.3 By Application

                                                6.1.3.4 By End User

                                                6.1.3.5 By Type

                                                6.1.3.6 By Product

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Technique

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                                6.1.4.5 By Type

                                                6.1.4.6 By Product

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Technique

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                                                6.1.5.5 By Type

                                                6.1.5.6 By Product

                                6.2 China             

                                6.3 India              

                                6.4 Japan            

                                6.5 Australia      

                                6.6 South Korea               

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Laboratories, Inc                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 F. Hoffmann-La Roche AG                    

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 Agilent Technologies                              

                8.5 Thermo Fisher Scientific, Inc.                              

                8.6 Merck KGaA                               

                8.7 PerkinElmer, Inc.                      

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of by end user, by Application type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. The Asia Pacific In situ Hybridization Market, By Technique, From 2021 to 2026 (USD Million)
  2. Asia Pacific FISH Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific CISH Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific In situ Hybridization Market, By Application, From 2021 to 2026 (USD Million)
  5. Asia Pacific Neuroscience Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia Pacific Cytology Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia Pacific Infectious Disease Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia Pacific In situ Hybridization Market, By End User, From 2021 to 2026 (USD Million)
  9. Asia Pacific Molecular Diagnostic Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia Pacific Academic And Research Institutions Market, By Region, From 2021 to 2026 (USD Million)
  11. Japan In situ Hybridization Market, By Technique, From 2021 to 2026 (USD Million)
  12. Japan In situ Hybridization Market, By Application, From 2021 to 2026 (USD Million)
  13. Japan In situ Hybridization Market, By End User, From 2021 to 2026 (USD Million)
  14. China In situ Hybridization Market, By Technique, From 2021 to 2026 (USD Million)
  15. China In situ Hybridization Market, By Application, From 2021 to 2026 (USD Million)
  16. China In situ Hybridization Market, By End User, From 2021 to 2026 (USD Million)
  17. India In situ Hybridization Market, By Technique, From 2021 to 2026 (USD Million)
  18. India In situ Hybridization Market, By Application, From 2021 to 2026 (USD Million)
  19. India In situ Hybridization Market, By End User, From 2021 to 2026 (USD Million)
  20. Australia In situ Hybridization Market, By Technique, From 2021 to 2026 (USD Million)
  21. Australia In situ Hybridization Market, By Application, From 2021 to 2026 (USD Million)
  22. Australia In situ Hybridization Market, By End User, From 2021 to 2026 (USD Million)
  23. South Korea In situ Hybridization Market, By Technique, From 2021 to 2026 (USD Million)
  24. South Korea In situ Hybridization Market, By Application, From 2021 to 2026 (USD Million)
  25. South Korea In situ Hybridization Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample